A Phase 2 Study of Mavacamten in Adults With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy (nHCM)

NCT03442764 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

59

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-obstructive Hypertrophic Cardiomyopathy

Interventions

DRUG: mavacamten
DRUG: Placebo

Sponsor

MyoKardia, Inc.